New Pediatric Eczema Guidelines Call for Personalized Atopic Dermatitis Treatment

July 10, 2026 UCBN News, Syndication Comments Off on New Pediatric Eczema Guidelines Call for Personalized Atopic Dermatitis Treatment
Stylized image of a young girl touching her chin with breakout photos of various phases and treatments of eczema.

The American Academy of Dermatology (AAD) has released its first evidence-based guidelines for preventing and treating atopic dermatitis, the most common type of eczema. The new guidelines are good news for the millions of children and adolescents living with itchy, inflamed skin caused by atopic dermatitis, according to a CU Anschutz pediatric dermatologist.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Actuate Announces Completion of Enrollment in a Phase 2 Trial of Elraglusib in Combination with FOLFIRINOX and Losartan in Patients with Previously Untreated Metastatic Pancreatic Cancer

February 25, 2025 UCBN News, Syndication Comments Off on Actuate Announces Completion of Enrollment in a Phase 2 Trial of Elraglusib in Combination with FOLFIRINOX and Losartan in Patients with Previously Untreated Metastatic Pancreatic Cancer

CHICAGO and FORT WORTH, Texas, Feb. 25, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers […]

No Picture
News

KromaTiD Launches dGH™ Cell Prep Kit

July 19, 2022 UCBN News Comments Off on KromaTiD Launches dGH™ Cell Prep Kit

LONGMONT, Colo., July 19, 2022 /PRNewswire/ — KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of their dGH™ […]